Tag: TRI TDS SVY

Alteogen Showcases ALT-B4’s Potential to Transform ADC Development at World ADC Summit 2026

Preclinical data demonstrate enhanced systemic exposure and bioavailability, reduced dermal toxicity, and improved safety profile in ALT-B4-enabled ADC therapyKey PointsSuperior PK: Subcutaneous administration of ADCs...

- A word from our sponsors -

HomeTagsTRI TDS SVY

Manulife Asia Care Survey 2026: Independence as Asia’s New Legacy

Manulife Asia Care Survey 2026: Independence as Asia’s New Legacy

CARPL.ai Partners with Enlitic to Accelerate AI Validation for Imaging Customers

Tag: TRI TDS SVY

Alteogen Showcases ALT-B4’s Potential to Transform ADC Development at World ADC Summit 2026

Explore

Press Releases

News & Opinion

Living

Others

Follow us